beta-lactams has been researched along with Necrosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Fayne, D; Malebari, AM; Meegan, MJ; Nathwani, SM; Noorani, S; O'Boyle, NM; O'Connell, F; O'Sullivan, J; Twamley, B; Zisterer, DM | 1 |
Pedersen, HB; Rosborg, J | 1 |
Bouchot-Hermouet, M; David, A; Hepner, Y; Lavergne-Hepner, D; Pannier, M; Stalder, JF | 1 |
Bogomolova, NS; Bol'shakov, LV; Drachennikova, AA | 1 |
4 other study(ies) available for beta-lactams and Necrosis
Article | Year |
---|---|
β-Lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; beta-Lactams; Binding Sites; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; HEK293 Cells; Humans; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Necrosis; Protein Binding; Stilbenes; Survivin; Tubulin; Tubulin Modulators | 2020 |
Necrotizing external otitis: aminoglycoside and beta-lactam antibiotic treatment combined with surgical treatment.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Debridement; Diabetes Complications; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Necrosis; Otitis Externa; Pseudomonas Infections; Recurrence; Retrospective Studies; Time Factors | 1997 |
[Beta-hemolytic streptococcal periorbital necrotizing fasciitis in a child].
Topics: Anti-Bacterial Agents; beta-Lactams; Child, Preschool; Fasciitis; Female; Humans; Necrosis; Orbital Diseases; Streptococcal Infections | 1991 |
[Efficacy of a combination of dioxidine with beta-lactam antibiotics in the prevention and treatment of purulent-inflammatory complications].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbon Dioxide; Diabetes Complications; Drug Therapy, Combination; Humans; Inflammation; Necrosis; Oxidation-Reduction; Oxygen; Partial Pressure; Quinoxalines; Suppuration | 1990 |